While the foundational principles of the 2013 American College of Cardiology and American Heart Association (ACC/AHA) guidelines on the use of statins for the management and prevention of cholesterol and cardiovascular disease (CVD) remain relevant, insights from the recent PREVENT study mean that predicted 10-year risk of atherosclerotic cardiovascular disease (ASCVD) can now be estimated with greater precision, experts say.